EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies

M Diana van Die iD, Kerry M Bone, Kala Visvanathan, Cecile Kyrø iD, Dagfinn Aune iD, Carolyn Ee, Channing J Paller iD

JNCI Cancer Spectrum · 04.01.2024 · 8 (1)

DOI: 10.1093/jncics/pkad104 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 09.12.2023. Verfasst von M Diana van Die und 6 weiteren Autor:innen. Beteiligte Einrichtung: NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phytonutrient intakes may improve outcomes following breast cancer, but the impact of postdiagnosis introduction vs established prediagnostic exposure as well as optimum doses has not been established. Evidence from observational studies for key exposures was evaluated, including dosage and intake time frames.

Methods

MEDLINE, EMBASE, CINAHL, Cochrane Library, ClinicalTrials.gov, and the ISRCTN registry were searched for prospective and retrospective observational studies investigating the impact of soybean, lignans, cruciferous (cabbage-family) vegetables, green tea, or their phytonutrients on breast cancer survival outcomes. A random-effects model was used to calculate summary hazard ratios (HRs) and 95% confidence intervals (CIs). Nonlinear dose-response analyses were conducted using restricted cubic splines.

Results

Thirty-two articles were included. Soy isoflavones were associated with a 26% reduced risk of recurrence (HR = 0.74, 95% CI = 0.60 to 0.92), particularly among postmenopausal (HR = 0.72, 95% CI = 0.55 to 0.94) and estrogen receptor–positive survivors (HR = 0.82, 95% CI = 0.70 to 0.97), with the greatest risk reduction at 60 mg/day. In mortality outcomes, the reduction was mostly at 20 to 40 mg/day. Soy protein and products were inversely associated with cancer-specific mortality for estrogen receptor–positive disease (HR = 0.75, 95% CI = 0.60 to 0.92). An inverse association was observed for serum or plasma enterolactone, measured prediagnosis and early postdiagnosis, with cancer-specific mortality (HR = 0.72, 95% CI = 0.58 to 0.90) and all-cause mortality (HR = 0.69, 95% CI = 0.57 to 0.83). No effects were observed for cruciferous vegetables. There was a 44% reduced risk of recurrence with prediagnostic green tea for stage I and II breast cancer (HR = 0.56, 95% CI = 0.38 to 0.83).

Conclusions

Soy, enterolactone, and green tea demonstrated significant risk reductions in outcomes following breast cancer. Evidence is needed regarding the impact of postdiagnostic introduction or substantial increase of these exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleProspective StudiesRetrospective StudiesReceptors, EstrogenTea4-ButyrolactoneLignans

Substanzen

Receptors, EstrogenTea2,3-bis(3'-hydroxybenzyl)butyrolactone4-ButyrolactoneLignans

Autor:innen und Institutionen

  • NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia.
  • Integria (MediHerb), Warwick, QLD, Australia.
  • Northeast College of Health Sciences, Seneca Falls, NY, USA.
  • Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Baltimore, MD, USA.
  • Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Department of Diet, Cancer and Health, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.

ORCID-Profile: M Diana van Die, Cecile Kyrø, Dagfinn Aune, Channing J Paller

Zitieren

APA

van Die, M. D., Bone, K. M., Visvanathan, K., Kyrø, C., Aune, D., Ee, C., & Paller, C. J. (2024). Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI Cancer Spectrum, 8(1). https://doi.org/10.1093/jncics/pkad104

Vancouver

van Die MD, Bone KM, Visvanathan K, Kyrø C, Aune D, Ee C, et al. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI Cancer Spectrum. 2024;8(1). doi:10.1093/jncics/pkad104

BibTeX
@article{vanDie2024,
  author = {van Die, M Diana and Bone, Kerry M and Visvanathan, Kala and Kyrø, Cecile and Aune, Dagfinn and Ee, Carolyn and Paller, Channing J},
  title = {Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  volume = {8},
  number = {1},
  doi = {10.1093/jncics/pkad104}
}
Kostenlos starten →